Submission Details
| 510(k) Number | K992918 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 30, 1999 |
| Decision Date | April 03, 2000 |
| Days to Decision | 217 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
K992918 is an FDA 510(k) clearance for the STC AMPHETAMINE-SPECIFIC INTERCEPT MICRO-PLATE EIA, MODEL 1103I, a Enzyme Immunoassay, Amphetamine (Class II — Special Controls, product code DKZ), submitted by OraSure Technologies, Inc. (Bethlehem, US). The FDA issued a Cleared decision on April 3, 2000, 217 days after receiving the submission on August 30, 1999. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3100.
| 510(k) Number | K992918 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 30, 1999 |
| Decision Date | April 03, 2000 |
| Days to Decision | 217 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
| Product Code | DKZ — Enzyme Immunoassay, Amphetamine |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3100 |